Amarin | AMRN - PE Price to Earnings

Stock Price
15.48
Daily Change
0.06 0.39%
Monthly
-1.02%
Yearly
86.51%
Q1 Forecast
14.88

Amarin reported 91.05 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin 91.05 88.3 Jun/2023
AstraZeneca 27.29 5.8 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 11.15 0.29 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
Heron Therapeutics 6.46 3.23 Dec/2006
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 15.74 0.15 Sep/2025